web analytics

Description

Ghossein et al evaluated patients with encapsulated Hurthle cell carcinomas of the thyroid gland for risk factors associated with recurrent disease. These can help identify patients who may require closer monitoring and more aggressive management. The authors are from Memorial Sloan-Kettering Cancer Center and Columbia University in New York City.


 

Patient selection: complete resection of an encapsulated Hurthle cell carcinoma

 

Criteria for an encapsulated Hurthle cell carcinoma:

(1) well-defined and encapsulated

(2) no macroscopic evidence of vascular or capsular invasion

(3) consists of 76-100% (> 75%) follicular oncocytic cells

 

The primary risk factor for recurrence was >= 4 foci of vascular invasion (termed extensive vascular invasion).

 

Histologic features associated with >= 4 foci of vascular invasion:

(1) solid /trabecular growth pattern (versus follicular pattern)

(2) mitotic rate >= 1 per 10 high powered fields (hpf, 400x total magnification)

 

The authors recommended that any encapsulate Hurthle cell tumor with solid/trabecular growth and/or mitotic activity should be diligently examined for foci of vascular invasion.

 

In univariate analysis, a tumor diameter > 4 cm was associated with decreased recurrence-free survival.

 


To read more or access our algorithms and calculators, please log in or register.